UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Post-Intensive Care Unit Follow-up of Pulmonary Embolism

Critical care clinics, 2020-07, Vol.36 (3), p.561-570

2020

Volltextzugriff (PDF)

Predictors of Waitlist Mortality in Portopulmonary Hypertension

Transplantation, 2017-07, Vol.101 (7), p.1609-1615

2017

Volltextzugriff (PDF)

Results From the United States Chronic Thromboembolic Pulmonary Hypertension Registry: Enrollment Characteristics and 1-Year Follow-up

Chest, 2021-11, Vol.160 (5), p.1822-1831

2021

Volltextzugriff (PDF)

Sex Differences in Portopulmonary Hypertension

Chest, 2021-01, Vol.159 (1), p.328-336

2021

Volltextzugriff (PDF)

Combination Therapy in Pulmonary Arterial Hypertension

The American journal of cardiology, 2013-04, Vol.111 (8), p.16C-20C

Channick, Richard N., MD

2013

Volltextzugriff (PDF)

Randomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension

American journal of respiratory and critical care medicine, 2006-12, Vol.174 (11), p.1257-1263

2006

Volltextzugriff (PDF)

A Multidisciplinary Pulmonary Embolism Response Team

Chest, 2013-11, Vol.144 (5), p.1738-1739

2013

Volltextzugriff (PDF)

Selexipag treatment for pulmonary arterial hypertension associated with congenital heart disease after defect correction: insights from the randomised controlled GRIPHON study

European journal of heart failure, 2019-03, Vol.21 (3), p.352-359

2019

Volltextzugriff (PDF)

Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension

The European respiratory journal, 2017-08, Vol.50 (2), p.1602493-1602493

2017

Volltextzugriff (PDF)

NEDD9 Is a Novel and Modifiable Mediator of Platelet-Endothelial Adhesion in the Pulmonary Circulation

American journal of respiratory and critical care medicine, 2021-06, Vol.203 (12), p.1533-1545

2021

Volltextzugriff (PDF)

Recommendations for Screening and Detection of Connective Tissue Disease–Associated Pulmonary Arterial Hypertension

Arthritis & rheumatology (Hoboken, N.J.), 2013-12, Vol.65 (12), p.3194-3201

2013

Volltextzugriff (PDF)

Contemporary trends in the diagnosis and management of pulmonary arterial hypertension: an initiative to close the care gap

Chest, 2013-02, Vol.143 (2), p.324-332

2013

Volltextzugriff (PDF)

Update on Medical Management of Pulmonary Arterial Hypertension

Cardiology clinics, 2022-02, Vol.40 (1), p.13-27

2022

Volltextzugriff (PDF)

Relationship Between Time From Diagnosis and Morbidity or Mortality in Pulmonary Arterial Hypertension: Results From the Phase III GRIPHON Study

Chest, 2021-07, Vol.160 (1), p.277-286

2021

Volltextzugriff (PDF)

Pulmonary Hypertension in Idiopathic Interstitial Pneumonia Is Associated with Small Vessel Pruning

American journal of respiratory and critical care medicine, 2024-05, Vol.209 (9), p.1170-1173

2024

Volltextzugriff (PDF)

Pregnancy and Pulmonary Hypertension: From Preconception and Risk Stratification Through Pregnancy and Postpartum

Heart failure clinics, 2023-01, Vol.19 (1), p.75-87

2023

Volltextzugriff (PDF)

SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension

European heart journal, 2017-04, Vol.38 (15), p.1147-1155

2017

Volltextzugriff (PDF)

Is Methamphetamine Use Associated With Idiopathic Pulmonary Arterial Hypertension?

Chest, 2006-12, Vol.130 (6), p.1657-1663

2006

Volltextzugriff (PDF)

Long-Term Safety, Tolerability and Survival in Patients with Pulmonary Arterial Hypertension Treated with Macitentan: Results from the SERAPHIN Open-Label Extension

Advances in therapy, 2022-09, Vol.39 (9), p.4374-4390

2022

Volltextzugriff (PDF)

Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial

Chest, 2017-01, Vol.151 (1), p.106-118

2017

Volltextzugriff (PDF)

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study

The Lancet (British edition), 2001-10, Vol.358 (9288), p.1119-1123

2001

Volltextzugriff (PDF)

Psychometric Validation of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire: Results of the SYMPHONY Trial

Chest, 2018-10, Vol.154 (4), p.848-861

2018

Volltextzugriff (PDF)

Perfusion imaging heterogeneity during NO inhalation distinguishes pulmonary arterial hypertension (PAH) from healthy subjects and has potential as an imaging biomarker

Respiratory research, 2022-12, Vol.23 (1), p.325-325, Article 325

2022

Volltextzugriff (PDF)

New paradigm for pulmonary arterial hypertension treatment

Current opinion in pulmonary medicine, 2016-09, Vol.22 (5), p.429-433

2016

Volltextzugriff (PDF)

Safety and tolerability of macitentan in the management of pulmonary arterial hypertension: an update

Drug, healthcare and patient safety, 2019-09, Vol.11, p.71-85

2019

Volltextzugriff (PDF)

26 – 50 von 332

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(310)
Mit Volltextzugriff
(268)

Publikationsform

Sprache

Englisch
(330)
Deutsch
(1)
Türkisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(179)
Life Sciences & Biomedicine
(178)
Humans
(144)
Respiratory System
(100)
Pulmonary Hypertension
(81)
Male
(78)
Female
(75)
Middle Aged
(66)
Cardiovascular System & Cardiology
(65)
Cardiac & Cardiovascular Systems
(64)
General & Internal Medicine
(62)
Adult
(55)
Pulmonary Arterial Hypertension
(55)
Critical Care Medicine
(54)
Biological And Medical Sciences
(50)
Hypertension, Pulmonary - Drug Therapy
(49)
Medical Sciences
(49)
Treatment Outcome
(39)
Hypertension, Pulmonary - Physiopathology
(38)
Aged
(36)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Post-Intensive Care Unit Follow-up of Pulmonary Embolism

Predictors of Waitlist Mortality in Portopulmonary Hypertension

Results From the United States Chronic Thromboembolic Pulmonary Hypertension Registry: Enrollment Characteristics and 1-Year Follow-up

Sex Differences in Portopulmonary Hypertension

Combination Therapy in Pulmonary Arterial Hypertension

Randomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension

A Multidisciplinary Pulmonary Embolism Response Team

Selexipag treatment for pulmonary arterial hypertension associated with congenital heart disease after defect correction: insights from the randomised controlled GRIPHON study

Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension

NEDD9 Is a Novel and Modifiable Mediator of Platelet-Endothelial Adhesion in the Pulmonary Circulation

Recommendations for Screening and Detection of Connective Tissue Disease–Associated Pulmonary Arterial Hypertension

Contemporary trends in the diagnosis and management of pulmonary arterial hypertension: an initiative to close the care gap

Update on Medical Management of Pulmonary Arterial Hypertension

Relationship Between Time From Diagnosis and Morbidity or Mortality in Pulmonary Arterial Hypertension: Results From the Phase III GRIPHON Study

Pulmonary Hypertension in Idiopathic Interstitial Pneumonia Is Associated with Small Vessel Pruning

Pregnancy and Pulmonary Hypertension: From Preconception and Risk Stratification Through Pregnancy and Postpartum

SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension

Is Methamphetamine Use Associated With Idiopathic Pulmonary Arterial Hypertension?

Long-Term Safety, Tolerability and Survival in Patients with Pulmonary Arterial Hypertension Treated with Macitentan: Results from the SERAPHIN Open-Label Extension

Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study

Psychometric Validation of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire: Results of the SYMPHONY Trial

Perfusion imaging heterogeneity during NO inhalation distinguishes pulmonary arterial hypertension (PAH) from healthy subjects and has potential as an imaging biomarker

New paradigm for pulmonary arterial hypertension treatment

Safety and tolerability of macitentan in the management of pulmonary arterial hypertension: an update

Suchergebnisse filtern